Oramed Pharmaceuticals Inc. Banner Image

Oramed Pharmaceuticals Inc.

  • Ticker ORMP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Oramed Pharmaceuticals Inc. Logo Image
  • 11-50 Employees
  • Based in Jerusalem, Israel
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in New York and Israel, Oramed has developed a novel Protein Oral Delivery (PODâ„¢) technology. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which hasMore the potential to be the first commercial oral insulin capsule for the treatment of diabetes. The Company has completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901.
4.8 / 5.0 (242)

Oramed Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 242 reviews.

Oramed Pharmaceuticals Inc.

Most Recent Annual Report

Oramed Pharmaceuticals Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Oramed Pharmaceuticals Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!